neuropeptides or multiple copies of a single neuropeptide may be released. Furthermore, a single precursor molecule can be cleaved at different sites resulting in different sets of peptides being produced in different cell types leading to an increase in neuropeptide complexity [10, 11] .
Post-translational modification may serve two important roles: (1) to confer biological activity or (2) to enhance the stability of the final peptide product [1] . Of all the modifications, C-terminal amidation, N-terminal pyroglutamic acid and acetylation are frequently encountered. Proopiomelanocortin (POMC) is a typical example of tissue-specific and posttranslational processing: adrenocorticotropic hormone (ACTH), a 39 amino acid unmodified peptide, is produced from POMC in the anterior pituitary, whereas α-melanocyte-stimulating hormone (α-MSH), a 13 amino acid which is both N-terminally acetylated and C-terminally amidated, is produced from the same precursor in the intermediate pituitary. Post-translational modification can also affect the affinity of peptides for their receptors, for example, the β-endorphin stimulation of opioid receptors is reduced by acetylation at the N-terminal end; and this modification produces analgesia [8] .
and to a lesser extent, prohormone/proprotein convertase 5A (also known as prohormone/proprotein convertase 6A) [8] . Metalloprotease and endothelin convertase families are considered as new endopeptidases [1] . The typical cleavage sites of the endopeptidases are at mono or dibasic residues; for example, Lys-Arg or Arg-Arg. The next stage of processing is the removal of C-terminal basic residues present in most processing intermediates. Carboxypeptidase E (CPE) is the exopeptidase primarily responsible for this C-terminal trimming, although carboxypeptidase D has also been shown to act in this role.
However, non-classical cleavage (such as cleavage at aliphatic and aromatic residues) has also been observed; for examples, endothelin converting enzyme-2,carboxypeptidase A5 and carboxypeptidase A6 [8] .
While there are predicted to be only around 100 genes that encode neuropeptide precursors, the observed diversity of biologically active peptides (in excess of 250) is the result of alternate splicing, proteolytic processing and posttranslational modification [9] . Many forms of neuropeptides can be produced from a single neuropeptide precursor; for example, a single neuropeptide, multiple distinct Kisspeptin, a 54 amino acid peptide (kisspeptin-54), was discovered by Lee et al. (1996) [24] . Kisspeptins are produced mainly by neuronal clusters at discrete hypothalamic nuclei [25] .
They are known as key regulators of GnRH neurons. and its N-terminally truncated form (kisspeptin-10) were reported as LH stimulators. Kisspeptin-10 was demonstrated to stimulate GnRH release in rat hypothalamic explants and in vivo with intracerebral injection in sheep [17] . The influence of kisspeptins on GnRH neurons and LH is mediated via the GPR54 receptor. studies, for example, NPY quantification [34] . These antibodybased techniques are simple, sensitive, specific, rapid and easily automated, however, only neuropeptide isoforms that interact with specific antibodies can be detected.
Traditionally, the primary structure of peptides has been obtained by Edman sequencing. The method was developed by Edman in 1950 and continues to play an important role in sequencing peptides or proteins [35] . Automated Edman degradation has been used for neuropeptide sequencing in many different species; for examples, NPY in porcine brain [36] , GnRH in dogfish brain [37] and periviscerokinins in insect perisympathetic organs [38] . Heine et al. (1997) successfully sequenced peptides in human urine samples by using an Edman-based sequencing technique [39] . Edman degradation sequencing is very sensitive, reliable and its interpretation is straight-forward, but it is restricted to pure peptides and cannot analyse peptides with N-terminal modifications, for example those modified by acetylation, formylation or pyroglutamination [35] . 
Neuropeptidomics
The high throughput discovery of neuropeptides has been enabled by a relatively new technique coined peptidomics [41] and is defined as the study of endogenous peptides present within the cell, tissue or an organism. The expressions "peptidome" and "peptidomics" came into use in 2001 [42] [43] [44] [45] .
Typical proteomics studies involve the digestion of proteins using trypsin or other proteases to yield peptides suitable for analysis by liquid chromatography (LC) coupled to mass spectrometry (MS). Peptidomics studies focus on the analysis of the native peptide forms, i.e. without ex vivo digestion. The technique has found application in the discovery, study and quantification of neuropeptides that were traditionally reliant on using the techniques in the previous section. Peptidomics offers advantages over these techniques due to its speed, sensitivity and capability in the simultaneous characterisation and quantification of neuropeptides. Hundreds to thousands of neuropeptides can be separated and identified in a single LC-MS/MS experiment [46] . corticosterone and insulin in rat blood [29] ; orexin A and NPY in the plasma and hypothalamus of rats [30] ; and galanin in rat brain [31] . Although RIA is a relatively sensitive technique capable of absolute quantification of peptide levels, due to its antibody-based detection method, it is not always specific for a single peptide isoform. RIAs either identify peptides based on their N-and/or C-terminal sequence or post-translational modified residues (e.g., phosphorylation, sulfation, acetylation, and glycosylation) [8] . However, unless specific antibodies are available for the different isoforms, RIAs do not distinguish between these modifications. Enzyme-linked immunosorbent assays (ELISA) which utilise antibodies along with a colourimetric reagent, have in part taken over from RIAs because of their ease of use, despite lower sensitivity in some cases [32, 33] . Commercial ELISA kits have been widely used in quantitative neuropeptide mixtures and is tolerant to the presence of salts, ESI can be easily interfaced with separation strategies such as LC and CE [1] . Due to its decreased susceptibility to impurities, MALDI is a direct tool for peptidomic analysis of biological samples. The singly charged ions produced in MALDI make it less complicated in terms of data interpretation compared to ESI in which multiple charge states are generated for larger peptides [47] . Typically MALDI ionisation is coupled with mass analysis using a time-offlight (TOF) mass analyser, whereas ESI ionisation may be found as the ionisation source associated with TOF, quadrupole, ion trap or hybrid mass analysers [48] .
MALDI-TOF MS has been used as a direct or LC-combined
technique to profile the peptidome of cell organelles, whole cells, tissues and organs of several species [47] 
Neuropeptidomics techniques and applications
The techniques used for neuropeptidome studies primarily involve MS, often coupled to peptide separation strategies such as high performance liquid chromatography (HPLC) or capillary electrophoresis (CE). Two commonly employed workflows are outlined in Figure 3 .
ESI versus MALDI
Mass spectrometry approaches have been successfully applied to the characterisation of neuropeptides from tissue extracts.
Two commonly used types of mass spectrometers in peptidomic research involve the use of electrospray ionisation (ESI) or matrixassisted laser desorption / ionisation (MALDI) [47] . They differ in the way the protein/peptides are ionised, and each of them has certain advantages. While MALDI is able to deal with complex 
Separation strategies
The diversity of neuropeptides present in tissue extracts varies greatly between different tissues or cells, ranging from hundreds to potentially thousands of neuropeptides in the brain, cerebrospinal fluid or blood. Furthermore, the complexity is confounded by the dynamic range within biological samples with endogenous peptide concentrations in the low pg/mL levels and highly abundant proteins in mg/mL concentrations [41] . For example, the high concentration of albumin in human plasma interferes with peptide analysis of low concentration biomarkers [63] [64] [65] . Thus, a separation, and sometimes depletion, is needed prior to peptide identification by MS.
HPLC is one of the most useful techniques for separating peptides from complex mixtures [1] . In contrast to proteomics, 2D-PAGE has limited application in peptidome analysis because the peptides are normally lower than 10 kDa which cannot be retained and visualised on a gel [41] . Hence, HPLC is more applicable, sensitive, robust and easily automated for peptide separation. In order to avoid the incidence of co-elution of peptides in complex mixtures and to improve sensitivity, micro or nanoscale LC (micro-or nano-LC) has been applied. The very low flow rates delivered by micro-or nano-LC results in an increased acquisition time allowing a greater number of peptides to be analysed or enables a longer time per analysis improving the spectral quality for low abundance peptides [41] .
For example, using nano-LC-ESI-QTOF-MS analysis, a total of 550 endogenous neuropeptides were identified in hypothalamic rat brain tissues [66] . In addition, numerous separation modes such as size exclusion, reversed-phase (RP) and ion exchange can be used in LC, however RP is more often employed [1] .
The complexity of the biological samples can be reduced by combining different separation modes (e.g. two-dimensional (2D) chromatography) before MS analysis. The application of 2D LC using strong cation exchange (SCX) chromatography to separate peptides in the first dimension and reversed-phase in the second dimension has resolved highly complex samples. Holm et al.
(2005) developed a 2D LC with SCX-RP approach to characterise peptides in rat brain and differentiate peptide expression in less and more distressed rats [67] . Ion exchange chromatography combined with RP is a popular choice for proteomic studies, but the combination of two stages of RP chromatography is still used with great success, especially for peptidomic studies. Besides LC, CE has been considered for peptide separation.
CE combined with MS (CE-MS) has become a popular tool in peptidomics because of its high efficiency, fast analysis time and low sample consumption [68] . To date, CE is frequently (2011) [49] and Hauser et al. (2011) [50] showed the feasibility of MALDI-TOF MS through the identification of neuropeptides in the water flea Daphnia pulex and the parasitic wasp Nasonia vitripennis respectively. The peptide extract can also be separated and fractionated using LC before loading on MALDI target plate. A diverse range of applications of MALDI-TOF MS in endogenous peptide analysis has been reported; for example, the discovery of active peptides in vesicles of the exocrine, a trial gland of Aplysia californica [51] , and its application in the study of invertebrate [52, 53] and vertebrate neurons [54] . Molluscan neurons were the first single cell studied by MALDI MS. Studies examining learning, memory and behaviour have been conducted on several marine and freshwater invertebrates (e.g. the molluscs A. californica and Lymnaea stagnalis) because of their simple nervous system and the relatively large size of their neurons. Furthermore, the MALDI imaging technique has evolved as a powerful tool to map neuropeptide distribution in complex organs [55] . MALDI imaging is comparable to immunohistochemistry in that the information derived from both techniques involves the localisation of specific peptides. The technique has been applied in neuropeptide profiling in rat spinal cord [56] , and in the localisation of multiple neuropeptides in the brain and neuroendocrine organs of the crab Cancer borealis [57] . Advantages of MALDI imaging over traditional methods include its relatively simple application and ability to produce valuable information pertaining to the spacial localisation of multiple target molecules simultaneously.
In ESI, the ions are produced as an aerosol from the liquid phase and transferred directly to the gas phase following desolvation [58] . As such, ESI can be directly coupled with LC or CE (online) (more detail in the next section). This enables ESI MS instruments to detect and fragment very low amounts of peptides/neuropeptides. Thus, ESI MS is a perfect tool for peptide profiling and amino acid sequencing [47] . The peptidome of the Drosophila CNS, the rat brain including the motor cortex, the striatum and the thalamus, and human urine have all been analysed by ESI approaches [59] . In addition, the application of ESI has improved the coverage of the rat brain neuropeptidome. 
Quantification of neuropeptides
The important contribution of peptidomics is not only in the identification of peptides present in tissues or brain regions, but also the determination of the biological activities of the peptides. of interest [81] . The MS analysis time is focused only on target analytes, wherein the precursor (or parent) ion and product (or fragment) ions are selected for ion transmission in quadrupoles 1 and 3 respectively. The resultant signal is proportional to the amount of analyte [80] . These measurements may be multiplexed allowing up to 1000 peptides to be analysed in a single run [82] . Therefore, MRM is one of the most sensitive and specific methods for quantification of known analytes [83] .
MRM has been extensively used in quantitative studies of small molecules in the pharmaceutical industry such as therapeutic agents (e.g. warfarin, triazolam, and antibiotics) [84] [85] [86] and drugs of abuse (e.g. heroin, cocaine and cannabinoids) [87, 88] .
MRM approaches have been recently extended to peptidomics;
for example, MRM studies have been conducted to quantify peptides in plasma and tissue biomarkers. Xi et al. (2012) developed an MRM method to detect NPY family neuropeptides present in human plasma [89] . Ling et al. (2010) showed the feasibility of MRM in identification of disease-related peptide biomarkers in human urine samples [90] . The technique has been applied to quantify the level of native peptides in the serum of hepatocellular cancer patients, chronic liver disease patients, and disease free controls [91] .
Bioinformatics
The automated identification of neuropeptides based on their MS and MS/MS data are facilitated by the use of software programs and algorithms such as Mascot [92] , SEQUEST [93] , X!Tandem [94] , Peaks Studio [95] , Phenyx [96] and ProteinPilot [97] . These databases have been constructed, e.g. Swepep [98] , to facilitate neuropeptide identification. Binary logistic and expert system tools such as the NeuroPred discovery tool are used to predict annotated prohormones [99, 100] . Consequently, the predicted peptide library can be used in MS analyses.
Neuropeptide identification can be obtained not only by protein database searches, but also by de novo peptide sequencing and/or peptide sequence tag search strategies [1] .
In the database search strategy, peptide spectra are compared increase or decrease in response to food intake in animals; that means the peptide could be a regulator/modulator of food intake or energy balance.
Isotope labelling and label-free quantification approaches [79] . Both the techniques were demonstrated to be effective tools in the relative quantification of neuropeptides [72] .
In addition to labelling techniques, the MS-based technique peptides remained intact [103] . This method has been shown to be more effective on fresh or thawed tissues than frozen tissues. In another method, the tissues were heated to 80°C by the microwave directly after the brain is removed. There was no evidence of degraded neuropeptides, however, degradation fragments of haemoglobin were produced [79] . It has been shown that the use of protease inhibitors does not inhibit proteolysis completely [104] . In recent years, thermal stabilisation has proven to be an effective tool in preventing protein degradation. The thermal stabilisation combines heat and pressure under vacuum and can be applied to frozen tissues [104] . This technique is able to retain post-translational modified peptides and is a very useful way to study the peptidome [105, 106] . with theoretical peptides derived from the protein database.
In contrast to protein database search strategies, de novo sequencing only chooses the best possible sequence which has the highest score from all linear amino acid combinations.
Due to the absence of prior database information, this approach is only suitable for high quality spectra and is time consuming and requires manual verification. Partial sequences (sequence tags) which are found by an integrated or separate de novo sequencing program represent a semi-automated strategy.
Obtained sequence tags can be used in BLAST searches against the genome or prohormone sequence of closely-related species.
Moreover, the combination of the three different methods gives the best chance of identification.
In summary, bioinformatics is a very important tool to predict or discover putative hormones in newly sequenced genomes and also has the ability to identify signalling peptides for prohormone confirmation. By integrating genome sequence data with the knowledge of peptide processing and distribution, bioinformatics is a complementary field that supports peptidomics [1] .
Neuropeptidomics challenges
Peptidomics was evolved from proteomics; however, at its current stage of development, a number of challenges remain. In proteomics studies, a protein is identified by one or more peptides derived from enzymatic cleavage. In the study of neuropeptides, each peptide has a specific biological function. Therefore, the aim of peptidomics is to identify the complete suite of neuropeptides present in a given sample [12] Bliss S.P., Navratil A.M., Xie J., Roberson M.S., GnRH signaling, the gonadotrope and endocrine control of fertility, Front Neuroendocrinol, 2010, 31, 322-340. [28] Xu K., Hong K.A., Zhou Z., Hauger R.L., Goldman D., Sinha R., Genetic modulation of plasma NPY stress response is suppressed in substance abuse: association with clinical outcomes, Psychoneuroendocrinology, 2012, 37, 554-564.
